Diagnosing Immune Thrombocytopenia.
Sachs UJ.
Hamostaseologie. 2019 Aug;39(3):250-258. doi: 10.1055/s-0039-1678739. Epub 2019 Feb 14.
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.
Broome CM, McDonald V, Miyakawa Y, Carpenedo M, Kuter DJ, Al-Samkari H, Bussel JB, Godar M, Ayguasanosa J, De Beuf K, Rodeghiero F, Michel M, Newland A; ADVANCE Investigator Study Group.
Lancet. 2023 Nov 4;402(10413):1648-1659. doi: 10.1016/S0140-6736(23)01460-5. Epub 2023 Sep 28.
Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia.
Newland AC, Sánchez-González B, Rejtő L, Egyed M, Romanyuk N, Godar M, Verschueren K, Gandini D, Ulrichts P, Beauchamp J, Dreier T, Ward ES, Michel M, Liebman HA, de Haard H, Leupin N, Kuter DJ.
Am J Hematol. 2020 Feb;95(2):178-187. doi: 10.1002/ajh.25680. Epub 2019 Dec 10.
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Wang J, Zhou C, Yao W, Wang Q, Min X, Chen G, Xu X, Li X, Xu F, Fang Y, Yang R, Yu G, Gong Y, Zhao J, Fan Y, Liu Q, Cao L, Yao Y, Liu Y, Li X, Wu J, He Z, Lu K, Jiang L, Hu C, Zhao W, Zhang B, Shi W, Zhang X, Cheng Y; CAPSTONE-1 Study Group.
Lancet Oncol. 2022 Jun;23(6):739-747. doi: 10.1016/S1470-2045(22)00224-8. Epub 2022 May 13.
Roxithromycin-Associated Acute Thrombocytopenia.
Rossi M, Capecchi M, Lazzerini PE.
Am J Case Rep. 2021 Jun 30;22:e932039. doi: 10.12659/AJCR.932039.
Flow cytometric detection of platelet-associated immunoglobulin in patients with immune thrombocytopenic purpura and nonimmune thrombocytopenia.
Huh HJ, Park CJ, Kim SW, Han SH, Jang S, Chi HS.
Ann Clin Lab Sci. 2009 Summer;39(3):283-8.
Platelet associated IgG, platelet mean life span and treatment with intravenous immunoglobulin in idiopathic thrombocytopenic purpura.
Nieminen U, Syrjälä M, Ikkala E, Myllylä G.
Eur J Haematol. 1988 Apr;40(4):326-31. doi: 10.1111/j.1600-0609.1988.tb00186.x.
Mean platelet size related to glycoprotein-specific autoantibodies and platelet-associated IgG.
Javela K, Kekomäki R.
Int J Lab Hematol. 2007 Dec;29(6):433-41. doi: 10.1111/j.1751-553X.2007.00885.x.
The clinical significance of platelet-associated IgG: a study on 298 patients with various disorders.
Mueller-Eckhardt C, Kayser W, Mersch-Baumert K, Mueller-Eckhardt G, Breidenbach M, Kugel HG, Graubner M.
Br J Haematol. 1980 Sep;46(1):123-31. doi: 10.1111/j.1365-2141.1980.tb05942.x.
Determination of optimal storage time and temperature for the detection of red blood cell and platelet surface-associated immunoglobulin by flow cytometry in healthy horses.
Frohlich M, Knights K, Springer NL.
Vet Immunol Immunopathol. 2023 Sep;263:110643. doi: 10.1016/j.vetimm.2023.110643. Epub 2023 Aug 14.
